Trial Profile

A first-in-human clinical trial evaluating N 17350

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 02 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs N-17350 (Primary)
Indications Cancer; Head and neck cancer; Skin cancer; Triple negative breast cancer
Focus Adverse reactions; First in man

Most Recent Events

25 Apr 2025 According to an Onchilles Pharma media release, company plans to initiate Phase 1 trial at the end of 2025 to validate the ELANE pathway in humans.
07 Nov 2024 According to Onchilles Pharma media release, company plans to initiate a Phase 1 trial of its lead candidate, N17350, in 2025 to validate the ELANE pathway in humans.
16 Dec 2022 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com